From the Midwest Rett Syndrome website - It appears that the Gillette Children's Specialty Healthcare (St Paul's Campus) has signed onto the phase III trial??
Gillette Children's participating in Neuren Pharmaceuticals conducting Phase II study of Trofinetide (NNZ-2256) in Rett Syndrome
***** Update (3/12/2018) - Phase III was approved by the FDA and is coming to Gillette soon! *****
https://www.midwestrett.org/news
From the Midwest Rett Syndrome website - It appears that the...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.25 |
Change
-0.100(0.81%) |
Mkt cap ! $1.565B | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.25 | $12.02 | $3.677M | 302.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1579 | $12.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.26 | 1199 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |